Replies to post #3998 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"The main advantage is safety."

I suppose by that you mean the safety that results from not having to use pooled blood from many donors as in the plasma derived products, and thus not be exposed to all sorts of potential transmitted diseases. Am I correct?